Amwill Health Care (BOM:544353) Beneish M-Score: -2.90 (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544353 Amwill Health Care Ltd BOM:544353
42 GF Score
Price ₹43.00
! 3 Warning Signs
View Full Analysis

What is Amwill Health Care Beneish M-Score?

Amwill Health Care BOM:544353 +1.18% 42 Beneish M-Score is -2.90 as of Aug. 04, 2026. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 115 Medical Distribution companies, Amwill Health Care ranks better than 80.87% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.9 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Amwill Health Care's Beneish M-Score or its related term are showing as below:

BOM:544353' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: 1.79   Max: 7.48
Current: -2.9

During the past 6 years, the highest Beneish M-Score of Amwill Health Care was 7.48. The lowest was -2.90. And the median was 1.79.

Amwill Health Care Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Amwill Health Care's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amwill Health Care Beneish M-Score Chart

Amwill Health Care Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial 0.00 -2.80 7.48 6.38 -2.90

Amwill Health Care Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Beneish M-Score Get a 7-Day Free Trial 7.48 0.00 6.38 0.00 -2.90

BOM:544353 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Amwill Health Care's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amwill Health Care Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Amwill Health Care's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Amwill Health Care's Beneish M-Score falls into.


BOM:544353
42GF Score
Amwill Health Care Ltd BOM:544353
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amwill Health Care Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Amwill Health Care for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1211+0.528 * 1.0213+0.404 * 0.2354+0.892 * 1.121+0.115 * 0.8494
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2696+4.679 * 0.039443-0.327 * 2.4072
=-2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹211.7 Mil.
Revenue was ₹454.9 Mil.
Gross Profit was ₹319.0 Mil.
Total Current Assets was ₹718.0 Mil.
Total Assets was ₹866.7 Mil.
Property, Plant and Equipment(Net PPE) was ₹10.9 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹5.5 Mil.
Selling, General, & Admin. Expense(SGA) was ₹62.1 Mil.
Total Current Liabilities was ₹57.9 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.
Net Income was ₹114.2 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹80.0 Mil.
 Total Receivables was ₹168.5 Mil.
Revenue was ₹405.8 Mil.
Gross Profit was ₹290.7 Mil.
Total Current Assets was ₹220.6 Mil.
Total Assets was ₹714.8 Mil.
Property, Plant and Equipment(Net PPE) was ₹11.6 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹4.6 Mil.
Selling, General, & Admin. Expense(SGA) was ₹43.6 Mil.
Total Current Liabilities was ₹19.9 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(211.716 / 454.923) / (168.467 / 405.816)
=0.465389 / 0.415131
=1.1211

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(290.673 / 405.816) / (319.039 / 454.923)
=0.716268 / 0.701303
=1.0213

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (718.029 + 10.944) / 866.703) / (1 - (220.609 + 11.551) / 714.773)
=0.158913 / 0.675198
=0.2354

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=454.923 / 405.816
=1.121

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(4.55 / (4.55 + 11.551)) / (5.456 / (5.456 + 10.944))
=0.282591 / 0.332683
=0.8494

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(62.081 / 454.923) / (43.619 / 405.816)
=0.136465 / 0.107485
=1.2696

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 57.945) / 866.703) / ((0 + 19.852) / 714.773)
=0.066857 / 0.027774
=2.4072

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(114.213 - 0 - 80.028) / 866.703
=0.039443

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Amwill Health Care has a M-score of -2.90 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.90 mean?
Amwill Health Care (BOM:544353) has a Beneish M-Score of -2.90 as of Aug. 04, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Amwill Health Care and its competitors. According to the industry distribution chart, Amwill Health Care ranks #22 out of 115 companies in the Medical Distribution industry, placing it in the top 19.1%.
Is Amwill Health Care's Beneish M-Score too high?
Amwill Health Care's current Beneish M-Score is -2.90. Based on the distribution chart, Amwill Health Care ranks #22 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's Beneish M-Score compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #22 out of 115 companies for Beneish M-Score. This places Amwill Health Care in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Distribution company?
A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Amwill Health Care and its competitors. Amwill Health Care's current Beneish M-Score is -2.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current Beneish M-Score of -2.90. The current Beneish M-Score is -2.90. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current Beneish M-Score is -2.90 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amwill Health Care Business Description

Address 2nd Main Road, No. 90, 4th Floor, 7th Cross, Chamrajpet, Bangalore, KA, IND, 560 018
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score

Get the complete analysis for BOM:544353

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.00
Price